117 related articles for article (PubMed ID: 4804100)
1. Ten years' experience with the use of thiazides in the prevention of kidney stones.
Yendt ER; Cohanim M
Trans Am Clin Climatol Assoc; 1974; 85():65-75. PubMed ID: 4804100
[No Abstract] [Full Text] [Related]
2. The effects of thiazides on serum and urinary zinc in patients with renal calculi.
Cohanim M; Yendt ER
Johns Hopkins Med J; 1975 Mar; 136(3):137-41. PubMed ID: 804069
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of recurrent calcic nephrolithiasis with thiazides. Clinico-metabolic evaluation].
Aroldi A; Antonacci A; Bonforte G; Surian M; Macchi E; Cantaluppi A; Graziani G
Minerva Nefrol; 1979; 26(3):315-9. PubMed ID: 262271
[No Abstract] [Full Text] [Related]
4. [Thiazides to prevent recurrence of kidney stones: is hydrochlorothiazide still indicated?].
Verploegen MFA; Nijenhuis T
Ned Tijdschr Geneeskd; 2023 Nov; 167():. PubMed ID: 37930159
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].
Ulmann A
Nephrologie; 1984; 5(5):232-4. PubMed ID: 6531063
[TBL] [Abstract][Full Text] [Related]
6. Thiazides and calcium urolithiasis.
Yendt ER; Cohanim M
Can Med Assoc J; 1978 Apr; 118(7):755-8. PubMed ID: 638900
[No Abstract] [Full Text] [Related]
7. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol.
Maschio G; Tessitore N; D'Angelo A; Fabris A; Pagano F; Tasca A; Graziani G; Aroldi A; Surian M; Colussi G; Mandressi A; Trinchieri A; Rocco F; Ponticelli C; Minetti L
Am J Med; 1981 Oct; 71(4):623-6. PubMed ID: 7282751
[TBL] [Abstract][Full Text] [Related]
8. [3 years' experience in the prevention of recurrent calcic nephrolithiasis].
Tessitore N; D'Angelo A; Pagano F; Loschiavo C; Fabris A; Lupo A; Tasca A; Morachiello P; Valvo E; Previato G; Chiaramonte S; Sidoti O; Maschio G
Minerva Nefrol; 1980; 27(2):267-70. PubMed ID: 7219849
[No Abstract] [Full Text] [Related]
9. The use of thiazides in the prevention of renal calculi.
Yendt ER; Guay GF; Garcia DA
Can Med Assoc J; 1970 Mar; 102(6):614-20. PubMed ID: 5437394
[TBL] [Abstract][Full Text] [Related]
10. The management of the patient with calcium stones.
Yendt ER; Cohanim M
Br J Urol; 1976; 48(7):507-14. PubMed ID: 1016824
[TBL] [Abstract][Full Text] [Related]
11. [Change in the prevention of kidney stones].
Derouet C; Kissling S; Roth B; Bonny O; Schwotzer N
Rev Med Suisse; 2024 Feb; 20(863):436-440. PubMed ID: 38415730
[TBL] [Abstract][Full Text] [Related]
12. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
Borghi L; Meschi T; Guerra A; Novarini A
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
[TBL] [Abstract][Full Text] [Related]
13. The effect of hydrochlorothiazide on the renal excretion of oxalic acid and on the formation of oxalate stones in the urinary tract.
Glazenburg J
Arch Chir Neerl; 1971; 23(3):217-23. PubMed ID: 5121595
[No Abstract] [Full Text] [Related]
14. Critical evaluation of various forms of therapy for idiopathic calcium stone disease.
Marangella M; Tricerri A; Sonego S; Ronzani M; Fruttero B; Daniele PG; Bruno M; Linari F
Proc Eur Dial Transplant Assoc; 1983; 20():434-9. PubMed ID: 6361754
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment of calcium nephrolithiasis (author's transl)].
Ulmann A
Nouv Presse Med; 1982 Apr; 11(18):1405-7. PubMed ID: 7079160
[TBL] [Abstract][Full Text] [Related]
16. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.
Taylor EN; Stampfer MJ; Curhan GC
J Am Soc Nephrol; 2004 Dec; 15(12):3225-32. PubMed ID: 15579526
[TBL] [Abstract][Full Text] [Related]
17. [Ion-exchange substances in the prevention of recurrence of calcium kidney stones].
Schneider HJ; Rugendorff EW
Arch Esp Urol; 1983; 36(2):124-32. PubMed ID: 6625683
[No Abstract] [Full Text] [Related]
18. [Compared metabolic effects of phosphorus or hydrochlorothiazide therapy in hypercalciuric stone-formers (author's transl)].
Dard S; Ulmann A
Nephrologie; 1981; 2(1):4-7. PubMed ID: 7345375
[TBL] [Abstract][Full Text] [Related]
19. [Physicochemical basis for the formation of calcium oxalate renal stones. Estimation of the degree of urine saturation with the activity product ratio (CPA) (author's transl)].
Peña JC; Fishleder S; Galván P; Herrera-Acosta J
Rev Invest Clin; 1981; 33(4):333-41. PubMed ID: 7330508
[No Abstract] [Full Text] [Related]
20. Prevention of recurrent stones in idiopathic hypercalciuria.
Muldowney FP
N Engl J Med; 2002 May; 346(21):1667-9. PubMed ID: 12030262
[No Abstract] [Full Text] [Related]
[Next] [New Search]
